Filed: 5/15/2026ACC: 0002106181-26-000004
📋 What this filing means
KALEHUA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $118.60M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$118.60M
Total AUM (reported)
22.30M
Total Shares
Allocation by class
COM$50.80M42.8%
COM NEW$36.26M30.6%
ALPHA ARCH 1-3$13.77M11.6%
COMMON STOCK$6.50M5.5%
SPONSORED ADS$4.53M3.8%
SHS$3.46M2.9%
CLASS A ORD$3.28M2.8%
Portfolio Concentration
Top 3$40.37M34.0%
4–10$44.49M37.5%
11–25$33.75M28.5%
Top 3 weight
34.0%
Top 10 weight
71.5%
Voting Authority Distribution
Total shares with voting rights: 22.30M
Sole
Full voting authority
22.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
X4 Pharmaceuticals Inc
SOLEShares3.72M
TypeSH
Market value$15.38M
12.96%
Sole
3.72M
Shared
0.00
None
0.00
Alpha Architect 1-3 Month Box ETF
SOLEShares118.42K
TypeSH
Market value$13.77M
11.61%
Sole
118.42K
Shared
0.00
None
0.00
Surrozen Inc
SOLEShares385.18K
TypeSH
Market value$11.22M
9.46%
Sole
385.18K
Shared
0.00
None
0.00
Relay Therapeutics Inc
SOLEShares901.46K
TypeSH
Market value$8.97M
7.56%
Sole
901.46K
Shared
0.00
None
0.00
Sionna Therapeutics Inc
SOLEShares197.07K
TypeSH
Market value$7.90M
6.66%
Sole
197.07K
Shared
0.00
None
0.00
Veradermics Inc
SOLEShares102.88K
TypeSH
Market value$6.50M
5.48%
Sole
102.88K
Shared
0.00
None
0.00
Oruka Therapeutics Inc
SOLEShares118.52K
TypeSH
Market value$5.81M
4.90%
Sole
118.52K
Shared
0.00
None
0.00
Pharvaris NV
SOLEShares198.77K
TypeSH
Market value$5.62M
4.73%
Sole
198.77K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares1.34M
TypeSH
Market value$5.02M
4.23%
Sole
1.34M
Shared
0.00
None
0.00
Septerna Inc
SOLEShares194.54K
TypeSH
Market value$4.67M
3.94%
Sole
194.54K
Shared
0.00
None
0.00
Compass Pathways PLC
SOLEShares819.69K
TypeSH
Market value$4.53M
3.82%
Sole
819.69K
Shared
0.00
None
0.00
Inhibikase Therapeutics Inc
SOLEShares2.67M
TypeSH
Market value$4.49M
3.79%
Sole
2.67M
Shared
0.00
None
0.00
LeonaBio Inc
SOLEShares393.70K
TypeSH
Market value$4.05M
3.41%
Sole
393.70K
Shared
0.00
None
0.00
Damora Therapeutics Inc
SOLEShares139K
TypeSH
Market value$3.60M
3.04%
Sole
139K
Shared
0.00
None
0.00
Uniqure NV
SOLEShares211.70K
TypeSH
Market value$3.46M
2.92%
Sole
211.70K
Shared
0.00
None
0.00
MoonLake Immunotherapeutics
SOLEShares175.73K
TypeSH
Market value$3.28M
2.76%
Sole
175.73K
Shared
0.00
None
0.00
Tyra Biosciences Inc
SOLEShares74.47K
TypeSH
Market value$2.85M
2.40%
Sole
74.47K
Shared
0.00
None
0.00
Gossamer Bio Inc
SOLEShares7.47M
TypeSH
Market value$2.45M
2.07%
Sole
7.47M
Shared
0.00
None
0.00
Tenaya Therapeutics Inc
SOLEShares2M
TypeSH
Market value$1.38M
1.17%
Sole
2M
Shared
0.00
None
0.00
PepGen Inc
SOLEShares729.96K
TypeSH
Market value$1.29M
1.09%
Sole
729.96K
Shared
0.00
None
0.00
Instil Bio Inc
SOLEShares139.85K
TypeSH
Market value$1.15M
0.97%
Sole
139.85K
Shared
0.00
None
0.00
Kalaris Therapeutics Inc
SOLEShares135.59K
TypeSH
Market value$782.3K
0.66%
Sole
135.59K
Shared
0.00
None
0.00
DiaMedica Therapeutics Inc
SOLEShares62.49K
TypeSH
Market value$423.0K
0.36%
Sole
62.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
X4 Pharmaceuticals IncSOLE | COM NEW | 3.72M | SH | $15.38M 12.96% | 3.72M | 0.00 | 0.00 |
Alpha Architect 1-3 Month Box ETFSOLE | ALPHA ARCH 1-3 | 118.42K | SH | $13.77M 11.61% | 118.42K | 0.00 | 0.00 |
Surrozen IncSOLE | COM NEW | 385.18K | SH | $11.22M 9.46% | 385.18K | 0.00 | 0.00 |
Relay Therapeutics IncSOLE | COM | 901.46K | SH | $8.97M 7.56% | 901.46K | 0.00 | 0.00 |
Sionna Therapeutics IncSOLE | COM | 197.07K | SH | $7.90M 6.66% | 197.07K | 0.00 | 0.00 |
Veradermics IncSOLE | COMMON STOCK | 102.88K | SH | $6.50M 5.48% | 102.88K | 0.00 | 0.00 |
Oruka Therapeutics IncSOLE | COM | 118.52K | SH | $5.81M 4.90% | 118.52K | 0.00 | 0.00 |
Pharvaris NVSOLE | COM | 198.77K | SH | $5.62M 4.73% | 198.77K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 1.34M | SH | $5.02M 4.23% | 1.34M | 0.00 | 0.00 |
Septerna IncSOLE | COM | 194.54K | SH | $4.67M 3.94% | 194.54K | 0.00 | 0.00 |
Compass Pathways PLCSOLE | SPONSORED ADS | 819.69K | SH | $4.53M 3.82% | 819.69K | 0.00 | 0.00 |
Inhibikase Therapeutics IncSOLE | COM NEW | 2.67M | SH | $4.49M 3.79% | 2.67M | 0.00 | 0.00 |
LeonaBio IncSOLE | COM | 393.70K | SH | $4.05M 3.41% | 393.70K | 0.00 | 0.00 |
Damora Therapeutics IncSOLE | COM NEW | 139K | SH | $3.60M 3.04% | 139K | 0.00 | 0.00 |
Uniqure NVSOLE | SHS | 211.70K | SH | $3.46M 2.92% | 211.70K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | CLASS A ORD | 175.73K | SH | $3.28M 2.76% | 175.73K | 0.00 | 0.00 |
Tyra Biosciences IncSOLE | COM | 74.47K | SH | $2.85M 2.40% | 74.47K | 0.00 | 0.00 |
Gossamer Bio IncSOLE | COM | 7.47M | SH | $2.45M 2.07% | 7.47M | 0.00 | 0.00 |
Tenaya Therapeutics IncSOLE | COM | 2M | SH | $1.38M 1.17% | 2M | 0.00 | 0.00 |
PepGen IncSOLE | COM | 729.96K | SH | $1.29M 1.09% | 729.96K | 0.00 | 0.00 |
Instil Bio IncSOLE | COM NEW | 139.85K | SH | $1.15M 0.97% | 139.85K | 0.00 | 0.00 |
Kalaris Therapeutics IncSOLE | COM | 135.59K | SH | $782.3K 0.66% | 135.59K | 0.00 | 0.00 |
DiaMedica Therapeutics IncSOLE | COM NEW | 62.49K | SH | $423.0K 0.36% | 62.49K | 0.00 | 0.00 |